Convection-Enhanced Delivery: Infusing Precision into Neurosurgery

Ariana Wilson and Mark Drlik seated against a white background, wearing lavalier microphones. The woman on the left has long brown curly hair and is wearing a beige cardigan over a taupe top. The man on the right is wearing glasses and a blue button-up shirt. They appear to be engaged in conversation or a video interview.
Resources

Convection-Enhanced Delivery: Infusing Precision into Neurosurgery

In this episode of MedDevice by Design, we explore how convection-enhanced delivery (CED) is transforming brain-targeted drug therapies. Ariana Wilson and Mark Drlik explain how this specialized method delivers therapeutic agents directly into brain tissue using precision-guided devices for safe and accurate infusion.

What Is Convection-Enhanced Delivery?

Convection-enhanced delivery is a neurosurgical technique that infuses medication directly into the brain. Unlike passive diffusion, CED uses pressure gradients to push molecules more uniformly and deeply into brain tissue. This approach enables better distribution of therapeutic agents to target areas.

Cannula Design

CED requires a rigid yet precise neurosurgical cannula. Surgeons place the cannula using a neuro-navigation system and preoperative imaging, which help chart the safest path into the brain. With over 600 kilometers of vasculature—equivalent to stacking 2,000 Eiffel Towers—avoiding blood vessels is critical.

Once placed, some cannulas become flexible to support long-term infusion and reduce infection risk by routing the tubing away from the wound site.

Navigating the Brain with Surgical Precision

Placing a cannula into the brain is a complex process. Neurosurgeons depend on real-time imaging and navigation tools to avoid sensitive areas. This level of surgical precision is what makes CED so promising for targeted brain therapies.

Split image showing two close-up views of a human eye. On the left, the eye is seen through thick black-framed glasses, indicating impaired vision. On the right, the same eye is enhanced with a futuristic digital overlay of concentric circles and interface elements, suggesting advanced vision restoration technology. A red curved arrow points from left to right, implying improvement. Bold text at the top reads "Restoring Vision?"

Ariana and Mark explore how accommodative intraocular lens technology may one day restore natural vision for people who require cataract surgery or suffer from presbyopia. As Mark shares, traditional bifocals are not ideal, and new lens solutions may offer better outcomes.

Brain-computer interface - A man wearing a brain-computer interface (BCI) headset sits in a clinical setting, concentrating as he appears to control a robotic arm with his mind. His head is overlaid with digital graphics representing brain activity. A doctor in a white lab coat stands nearby, monitoring the interaction. Onscreen data displays in the background suggest medical or neurological analysis. Bold text on the image reads "Brain-Controlled Tech?"

We explore the world of brain-computer interfaces (BCIs) and the challenges of capturing thought into action. Mark Drlik and Ariana Wilson walk through how these systems translate brain activity into control signals for devices—without needing surgical implants.

X-ray image of a human chest showing bones in high contrast. A visible electronic device, likely a pacemaker or implant, is located in the upper left chest area. A bold red arrow points to the device with a label in black and white text reading “definitely not bone.”

Mark and Ariana explore the surprising versatility of barium sulfate—a material used widely in both diagnostic procedures and medical device manufacturing. While many recognize it as the contrast agent you drink before an X-ray, it’s also a key additive that enhances plastic components across the healthcare industry.

Gloved hand holding a test tube filled with red liquid, with a large red arrow pointing at the tube on a blue gradient background.

We explore a groundbreaking shift in how Alzheimer’s disease may soon be diagnosed. Instead of relying on invasive spinal taps or costly PET scans, researchers have developed a blood test that detects key proteins associated with the disease—offering a more accessible and patient-friendly screening method.